Emvita 5
- Manufacturer
- RUBIMED AG
- Effective date
- 2024-10-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:29:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts Active Ingredients: (HPUS*) 16.7% of each
Bufo rana 800C Cuprum metallicum 18LM
Glandula suprarenalis 21X Phosphorus 21X
Pulsatilla 16LM Zincum metallicum 21X
*The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS & USAGE SECTION
Uses: (†) Homeopathic remedy for general well being: nervousness.
WARNINGS SECTION
Warnings:
Stop use if symptoms persist or worsen.
If you are pregnant or breastfeeding,consult a healthcare professional prior to use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions: (adults & children 6 years & older)
Take 12 drops 2 times daily, or as recommended by your health care professional.
OTHER SAFETY INFORMATION
Other information: Store at 20 - 25°C
(68 - 77°F.) Do not use if box has been
tampered with, or if the safety seal of the
bottle is broken.
INACTIVE INGREDIENT SECTION
Inactive ingredients:Ethanol 20% USP,
Purified Water.
OTC - QUESTIONS SECTION
Manufactured by: OHM pharma, Inc, USA.
Distributed by: Privia Naturals, LLC.
9169 W State St #196
Garden City, ID 83714
Info@privianaturals.com Product of USA.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 66343-092-60
RUBIMED
Emvita 5
Homeopathic Medicine For
General Well-being:
Nervousness
2.0 fl oz. 59mL 20% Ethanol
OTC - PURPOSE SECTION
Homeopathic Medicine For
General Well-being:
Nervousness
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c599c4a0-705d-4ebb-ab1f-977af038f96a | Product name | 1 | 20251124 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66343-092-60 | Emvita 5 | 60 mL in 1 BOTTLE | LIQUID | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66343-092 | EMVITA 5 (BUFO RANA, CUPRUM METALLICUM, GLANDULA SUPRARENALIS, PHOSPHORUS, PULSATILLA, ZINCUM METALLICUM) LIQUID [RUBIMED AG] | 2 | Current NDC, Legacy NDC, 1 package rows | 20241201_2a141ded-a864-422f-8eb4-69d65fb59c15.zip |
Products#
Every source-derived product name is available through these pages.
- Emvita 5
- Bufo rana, Cuprum metallicum, Glandula suprarenalis, Phosphorus, Pulsatilla, Zincum metallicum
- ALCOHOL
- WATER
- BUFO BUFO CUTANEOUS GLAND
- COPPER
- SUS SCROFA ADRENAL GLAND
- PHOSPHORUS
- PULSATILLA VULGARIS WHOLE
- ANEMONE PULSATILLA
- ZINC
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 66343-092 | 66343-092-60 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| BUFO BUFO CUTANEOUS GLAND | Q59QU6N72Q | ACTIB |
| COPPER | 789U1901C5 | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| PULSATILLA VULGARIS WHOLE | I76KB35JEV | ACTIB |
| ZINC | J41CSQ7QDS | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Emvita 5 | BUFO RANA, CUPRUM METALLICUM, GLANDULA SUPRARENALIS, PHOSPHORUS, PULSATILLA, ZINCUM METALLICUM | RUBIMED AG | 2a141ded-a864-422f-8eb4-69d65fb59c15 | 2024-10-29 | Warnings | 66343-092-60 66343-092 66343009260 2817dd5d-4be8-2e80-e063-6394a90acfd9 2a141ded-a864-422f-8eb4-69d65fb59c15 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

